Home
Site Map
Press Room
Press Releases
Contact Us
Clinical Trials
Phase 3 — Hepatocellular Carcinoma (HCC)
Phase 3 — Metastatic Colorectal Cancer (MCRC)
Phase 2 — Benign Prostatic Hyperplasia (BPH)
Phase 1 — Benign Prostatic Hyperplasia (BPH)
Pipeline
Hepatocellular Carcinoma (HCC)
Metastatic Colorectal Cancer (MCRC)
Benign Prostatic Hyperplasia (BPH)
Aptocine™
Aptocine™ Advantages
Publications
The Company
Executive Team
Board of Directors
Careers
Contact LSO
The Company
Executive Team
Lisa Koch-Hulle
Robert Littauer
Board of Directors
Careers
Contact LSO
Executive Team
Lisa Koch-Hulle
VP Clinical Operations and Regulatory Affairs
Robert Littauer
VP Chief Financial Officer
